HWA
ABBV icon

Hilltop Wealth Advisors’s AbbVie ABBV Stock Holding History

Hilltop Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307K Buy
1,220
+74
+6% +$15.9K 0.15% 55
2026
Q1 		$249K Buy
1,146
+16
+1% +$3.55K 0.15% 47
2025
Q4 		$258K Sell
1,130
-173
-13% -$39.4K 0.13% 48
2025
Q3 		$302K Buy
1,303
+25
+2% +$5.09K 0.16% 43
2025
Q2 		$237K Buy
1,278
+9
+0.7% +$1.67K 0.13% 46
2025
Q1 		$266K Sell
1,269
-72
-5% -$14K 0.15% 45
2024
Q4 		$238K Buy
1,341
+45
+3% +$8.27K 0.12% 47
2024
Q3 		$256K Buy
1,296
+21
+2% +$3.92K 0.12% 41
2024
Q2 		$219K Buy
1,275
+71
+6% +$11.8K 0.11% 48
2024
Q1 		$219K Sell
1,204
-125
-9% -$21.5K 0.11% 46
2023
Q4 		$206K Sell
1,329
-45
-3% -$6.56K 0.12% 39
2023
Q3 		$205K Buy
+1,374
New +$202K 0.16% 36
2023
Q2 		– Sell
-1,324
Closed -$211K – 36
2023
Q1 		$211K Sell
1,324
-492
-27% -$75.2K 0.17% 35
2022
Q4 		$293K Buy
+1,816
New +$278K 0.25% 31

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hilltop Wealth Advisors's ABBV Position: Q2 2026 in Review

Hilltop Wealth Advisors increased its AbbVie (ABBV) stake by 6.5% in Q2 2026, buying an estimated $15.9K and bringing the position to 1,220 shares worth $307K. The position accounts for 0.15% of the portfolio, ranked #55.

Hilltop Wealth Advisors first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hilltop Wealth Advisors held 1,220 shares of AbbVie worth $307K as of Q2 2026.
  • Hilltop Wealth Advisors bought 74 AbbVie shares in Q2 2026, an estimated $15.9K.
  • AbbVie made up 0.15% of Hilltop Wealth Advisors's portfolio in Q2 2026, its #55 holding.
  • Hilltop Wealth Advisors first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hilltop Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.